Skip to main content

CAPREIT Announces October 2022 Distribution

TORONTO, Oct. 17, 2022 (GLOBE NEWSWIRE) — Canadian Apartment Properties Real Estate Investment Trust (“CAPREIT”) (TSX – CAR.UN) announced today its October 2022 monthly distribution in the amount of $0.12084 per Unit (or $1.45 on an annualized basis). The October distribution will be payable on November 15, 2022 to Unitholders of record on October 31, 2022. CAPREIT is Canada’s largest publicly-traded provider of quality rental housing. CAPREIT currently owns or has interests in approximately 67,000 residential apartment suites, townhomes and manufactured housing community sites well-located across Canada and the Netherlands with approximately $18 billion of assets under management globally. Since its Initial Public Offering in May 1997, CAPREIT has grown monthly cash distributions per Unit by 103%. For more information about CAPREIT,...

Continue reading

ERES REIT Declares October 2022 Monthly Distribution

TORONTO, Oct. 17, 2022 (GLOBE NEWSWIRE) — European Residential Real Estate Investment Trust (TSX: ERE.UN, “ERES”) is pleased to announce that the trustees of ERES have declared the October 2022 monthly cash distribution of €0.01 per Unit and Class B LP Unit (the “October Distribution”), being equivalent to €0.12 per Unit annualized. The distribution will be payable to holders of the Units and Class B LP Units (the “Unitholders”) of record on October 31, 2022, with payment on November 15, 2022. The Euro-denominated distribution will be paid in Canadian dollars based on the exchange rate on the date of payment (estimated C$0.01344 per Unit and Class B LP Unit). Registered Unitholders will be provided with an option to elect to receive such distribution in Euros rather than Canadian dollars. If no such election is made, registered...

Continue reading

Northview Fund Announces October Distribution

Not for distribution to U.S. newswire services or for dissemination in the United States. CALGARY, Alberta, Oct. 17, 2022 (GLOBE NEWSWIRE) — Northview Fund (the “Fund”) today announced its October 2022 cash distribution amounts on its outstanding Class A Units, Class C Units and Class F Units Class (collectively, the “Units”), payable on November 15, 2022 to holders of Units of record at October 31, 2022. The distribution amounts will be as follows:C$0.10476 per Class A Unit, representing approximately C$1.26 per Unit on an annualized basis; C$0.11056 per Class C Unit, representing approximately C$1.33 per Unit on an annualized basis; C$0.10807 per Class F Unit, representing approximately C$1.30 per Unit on an annualized basis;About Northview Fund The Fund is a “closed-end fund” established pursuant to a declaration of trust...

Continue reading

Caldwell U.S. Dividend Advantage Fund Declares Distributions for Q4 2022

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, Oct. 17, 2022 (GLOBE NEWSWIRE) — Caldwell Investment Management Ltd. (“CIM”), the manager of Caldwell U.S. Dividend Advantage Fund (the “Fund”) is pleased to announce the payment of distributions on the actively-managed ETF Series of the Fund to unitholders of record as indicated below. The monthly distribution rate of CAD$0.038 per unit of the ETF Series represents an attractive annualized yield on net assets of approximately 3.2%.Record Date Payment Date Distribution per UnitOctober 28, 2022 November 4, 2022 CAD $0.038November 29, 2022 December 7, 2022 CAD $0.038December 29, 2022 January 6, 2023 CAD $0.038ETF Series unitholders also have the option to participate in the distribution reinvestment plan (“DRIP”)...

Continue reading

Royalty Pharma Declares Fourth Quarter 2022 Dividend

NEW YORK, Oct. 17, 2022 (GLOBE NEWSWIRE) — The board of directors of Royalty Pharma plc (Nasdaq: RPRX) has approved the payment of a dividend for the fourth quarter of 2022 of $0.19 per Class A ordinary share. The dividend will be paid on December 15, 2022, to shareholders of record at the close of business on November 18, 2022. About Royalty Pharma Founded in 1996, Royalty Pharma is the largest buyer of biopharmaceutical royalties and a leading funder of innovation across the biopharmaceutical industry, collaborating with innovators from academic institutions, research hospitals and non-profits through small and mid-cap biotechnology companies to leading global pharmaceutical companies. Royalty Pharma has assembled a portfolio of royalties which entitles it to payments based directly on the top-line sales of many of the industry’s...

Continue reading

Extendicare Announces October 2022 Dividend of C$0.04 per Share

MARKHAM, Ontario, Oct. 17, 2022 (GLOBE NEWSWIRE) — Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced that it has declared a cash dividend of C$0.04 per common share of the Company (the “Common Share”) for the month of October 2022, which is payable on November 15, 2022 to shareholders of record at the close of business on October 31, 2022. This dividend is designated as an “eligible dividend” within the meaning of the Income Tax Act (Canada). About Extendicare Extendicare is a leading provider of care and services for seniors across Canada, operating under the Extendicare, ParaMed, Extendicare Assist, and SGP Purchasing Partner Network brands. We are committed to delivering quality care throughout the health continuum to meet the needs of a growing seniors population. We operate or provide contract services...

Continue reading

Guardian Capital Announces October 2022 Distributions for Guardian Capital ETFs

TORONTO, Oct. 17, 2022 (GLOBE NEWSWIRE) — Guardian Capital LP announces the following regular cash distributions for the period ending October 31, 2022, in respect of the ETF series of the Guardian Capital funds listed below (the “Guardian Capital ETFs”). In each case, the distribution will be paid on October 31, 2022 to unitholders of record on October 25, 2022. The ex-dividend date in each case is October 24, 2022.  Guardian Capital ETFs Series of ETFUnits DistributionFrequency TSX TradingSymbol Distribution Amount(per ETF Unit)Guardian Directed Equity Path ETF Hedged ETF Units Monthly GDEP $0.0746Guardian Directed Equity Path ETF Unhedged ETF Units Monthly GDEP.B $0.0684Guardian Directed Premium Yield ETF Hedged ETF Units Monthly GDPY $0.1231Guardian Directed Premium Yield ETF Unhedged ETF Units Monthly GDPY.B $0.1133GuardPathTM...

Continue reading

New York Mortgage Trust Provides Preliminary Estimates of Third Quarter 2022 Financial Results and Announces Date of Third Quarter 2022 Conference Call

NEW YORK, Oct. 17, 2022 (GLOBE NEWSWIRE) — New York Mortgage Trust, Inc. (Nasdaq: NYMT) (“NYMT,” the “Company,” “we,” “our” or “us”) today announced preliminary estimates of select financial information as of and for the quarter ended September 30, 2022 in light of sustained market volatility. Preliminary Estimates of Select Financial Information for Third Quarter 2022Book value per common share. Book value per common share at September 30, 2022 was estimated to be between $3.62 and $3.66 compared to $4.06 per common share at June 30, 2022.Undepreciated book value per common share1. Undepreciated book value per common share at September 30, 2022 was estimated to be between $3.86 and $3.90 compared to $4.24 per common share at June 30, 2022.Company recourse leverage ratio2 and portfolio recourse leverage ratio3. Company recourse...

Continue reading

Sprague Resources LP Announces the Cash Distribution and Financial Results Release Date for the Third Quarter of 2022

Sprague announces a cash distribution of $0.4338 per unit PORTSMOUTH, N.H., Oct. 17, 2022 (GLOBE NEWSWIRE) — Sprague Resources LP (“Sprague” or the “Partnership”) (NYSE: SRLP) announced today that the Board of Directors of its general partner, Sprague Resources GP LLC (the “General Partner”), declared a cash distribution of $0.4338 per unit ($1.73 per unit on an annualized basis) for the quarter ended September 30, 2022, and is equal to the previous quarter’s distribution.   The announced distribution will be paid on Monday, October 31, 2022, to unitholders of record as of the close of business on Thursday, October 27, 2022. As announced and described in our Form 8-K filing with the Securities and Exchange Commission on June 2, 2022, Sprague, and its general partner, Sprague Resources GP LLC, entered into an Agreement and Plan...

Continue reading

Peyto Exploration & Development Corp. Confirms Monthly Dividend for November 15, 2022

CALGARY, Alberta, Oct. 14, 2022 (GLOBE NEWSWIRE) — Peyto Exploration & Development Corp. (TSX: PEY) (“Peyto”) confirms that the monthly dividend with respect to October 2022 of $0.05 per common share is to be paid on November 15, 2022, for shareholders of record on October 31, 2022. The ex-dividend date for the October dividend is October 28, 2022. Dividends paid by Peyto to Canadian residents are eligible dividends for Canadian income tax purposes. Shareholders and interested investors are encouraged to visit the Peyto website at www.peyto.com to learn more about what makes Peyto one of North America’s most exciting energy companies. The website also includes a monthly report, which discusses various topics chosen by the CEO and includes estimates of monthly capital expenditures and production. For further information...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.